A dual perspective on first-session therapeutic alliance: strong predictor of youth mental health and addiction treatment outcome.


Journal

European child & adolescent psychiatry
ISSN: 1435-165X
Titre abrégé: Eur Child Adolesc Psychiatry
Pays: Germany
ID NLM: 9212296

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 09 07 2019
accepted: 25 02 2020
pubmed: 12 3 2020
medline: 1 12 2020
entrez: 12 3 2020
Statut: ppublish

Résumé

We investigated the potential role of first-session therapeutic alliance ratings to serve as an early marker of treatment outcome in youth mental health and addiction treatment. The present study is among the first to incorporate both a youths' and a therapists' perspective of the therapeutic alliance in order to maximize predictive value of the alliance for treatment outcome. One hundred and twenty-seven adolescents participated in a multi-site prospective naturalistic clinical cohort study, with assessments at baseline and at 4 months post-baseline. Main outcome measure was favorable or unfavorable treatment outcome status at 4-month follow-up. Early therapeutic alliance had a medium and robust association with treatment outcome for youth' (b = 1.29) and therapist' (b = 1.12) perspectives and treatment setting. Based on the two alliance perspectives four subgroups were distinguished. Incorporating the alliance-ratings from both perspectives provided a stronger predictor of treatment outcome than using one perspective. Youth with a strong alliance according to both perspectives had an eightfold odds of favorable treatment outcome compared with youth with a weak alliance according to both perspectives. The association between therapeutic alliance and treatment outcome in youth mental health and addiction treatment may be substantially stronger than earlier assumed when both a youths' and therapists' perspective on alliance is considered.

Identifiants

pubmed: 32157389
doi: 10.1007/s00787-020-01503-w
pii: 10.1007/s00787-020-01503-w
pmc: PMC7595997
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1593-1601

Subventions

Organisme : ZonMw
ID : 729101014

Références

J Consult Clin Psychol. 1991 Feb;59(1):12-9
pubmed: 2002127
J Emot Behav Disord. 2015 Jun 1;23(2):90-100
pubmed: 25960629
Clin Psychol Rev. 2017 Jul;55:41-55
pubmed: 28501021
J Child Psychol Psychiatry. 2016 May;57(5):625-32
pubmed: 26647901
Clin Psychol Rev. 2013 Jul;33(5):698-711
pubmed: 23742782
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6
pubmed: 9255702
Assessment. 2020 Oct;27(7):1476-1489
pubmed: 30295054
Adm Policy Ment Health. 2012 Mar;39(1-2):78-89
pubmed: 22407555
Psychotherapy (Chic). 2018 Dec;55(4):316-340
pubmed: 29792475
Clin Psychol Rev. 2003 Feb;23(1):1-33
pubmed: 12559992
Am Psychol. 2017 Feb-Mar;72(2):79-117
pubmed: 28221063
J Child Psychol Psychiatry. 2018 Jan;59(1):5-19
pubmed: 28681928
Child Abuse Negl. 1995 Apr;19(4):419-31
pubmed: 7606521
J Consult Clin Psychol. 2009 Apr;77(2):203-11
pubmed: 19309180
Psychotherapy (Chic). 2018 Dec;55(4):341-355
pubmed: 30335449
J Subst Abuse Treat. 2013 Feb;44(2):145-58
pubmed: 22763198
Am J Addict. 2006;15 Suppl 1:26-33
pubmed: 17182417
Psychotherapy (Chic). 2018 Dec;55(4):520-537
pubmed: 30335463
J Consult Clin Psychol. 2010 Apr;78(2):144-55
pubmed: 20350026
Clin Psychol Psychother. 2015 Jan-Feb;22(1):1-14
pubmed: 24115489
Annu Rev Clin Psychol. 2019 May 7;15:207-231
pubmed: 30550721
Clin Child Psychol Psychiatry. 2015 Oct;20(4):640-56
pubmed: 25013127
Eur J Psychotraumatol. 2015 Aug 31;6:27705
pubmed: 26328753
Addiction. 2010 May;105(5):862-71
pubmed: 20331557
J Am Acad Child Adolesc Psychiatry. 2010 Oct;49(10):980-9
pubmed: 20855043
Eur Child Adolesc Psychiatry. 2003 Dec;12(6):281-9
pubmed: 14689260
J Clin Child Adolesc Psychol. 2008 Jul;37(3):631-9
pubmed: 18645753
Psychol Med. 2015 Jan;45(2):345-60
pubmed: 25066533
Eur Child Adolesc Psychiatry. 2015 May;24(5):553-63
pubmed: 25183369
Clin Psychol Rev. 2008 Oct;28(7):1167-87
pubmed: 18538907

Auteurs

Patty van Benthem (P)

Parnassia Addiction Research Center (PARC), Brijder Addiction Care, Zoutkeetsingel 40, 2512 HN, The Hague, The Netherlands. p.vanbenthem@brijder.nl.
Department of Child and Adolescent Psychiatry, Curium-LUMC, Leiden University Medical Center, Leiden, The Netherlands. p.vanbenthem@brijder.nl.

Renske Spijkerman (R)

Parnassia Addiction Research Center (PARC), Brijder Addiction Care, Zoutkeetsingel 40, 2512 HN, The Hague, The Netherlands.

Peter Blanken (P)

Parnassia Addiction Research Center (PARC), Brijder Addiction Care, Zoutkeetsingel 40, 2512 HN, The Hague, The Netherlands.

Marloes Kleinjan (M)

Epidemiology and Research Support, Trimbos Institute: Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands.
Department of Interdisciplinary Social Science, Youth Studies, Utrecht University, Utrecht, The Netherlands.

Robert R J M Vermeiren (RRJM)

Department of Child and Adolescent Psychiatry, Curium-LUMC, Leiden University Medical Center, Leiden, The Netherlands.
Youz, Parnassia Group, The Hague, The Netherlands.

Vincent M Hendriks (VM)

Parnassia Addiction Research Center (PARC), Brijder Addiction Care, Zoutkeetsingel 40, 2512 HN, The Hague, The Netherlands.
Department of Child and Adolescent Psychiatry, Curium-LUMC, Leiden University Medical Center, Leiden, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH